Search

Your search keyword '"Catte, O"' showing total 7 results
Start Over Author "Catte, O"
7 results on '"Catte, O"'

1. Prevalence of obesity and diabetes in older people with sarcopenia defined according to EWGSOP2 and FNHI criteria

Author

Remelli F., Maietti E., Abete P., Bellelli G., Bo M., Cherubini A., Corica F., Di Bari M., Maggio M., Rizzo M. R., Rossi A. P., Landi F., Volpato S., Brombo G., Ortolani B., Savino E., Fisichella A., Butto V., Zamboni M., Caliari C., Ferrari E., Orso F., Sacco F., Di Meo M. L., Cerri A. P., Motta M., Pittella F., Bonfanti A., Fusco S., Schepisi R., Ferro C., Catalano A., Caruso S., Soraci L., Marchese L., Agosta L., Basile C., Coppola C., Dalise A. M., Fava I., Catte O., Orru' M., Salaris P., Martone A. M., Ortolani E., Salini S., dell'Aquila G., Carrieri B., Remelli, F, Maietti, E, Abete, P, Bellelli, G, Bo, M, Cherubini, A, Corica, F, Di Bari, M, Maggio, M, Rizzo, M, Rossi, A, Landi, F, Volpato, S, Remelli, F., Maietti, E., Abete, P., Bellelli, G., Bo, M., Cherubini, A., Corica, F., Di Bari, M., Maggio, M., Rizzo, M. R., Rossi, A. P., Landi, F., Volpato, S., Remelli F., Maietti E., Abete P., Bellelli G., Bo M., Cherubini A., Corica F., Di Bari M., Maggio M., Rizzo M.R., Rossi A.P., Landi F., Volpato S., Brombo G., Ortolani B., Savino E., Fisichella A., Butto V., Zamboni M., Caliari C., Ferrari E., Orso F., Sacco F., Di Meo M.L., Cerri A.P., Motta M., Pittella F., Bonfanti A., Fusco S., Schepisi R., Ferro C., Catalano A., Caruso S., Soraci L., Marchese L., Agosta L., Basile C., Coppola C., Dalise A.M., Fava I., Catte O., Orru' M., Salaris P., Martone A.M., Ortolani E., Salini S., dell'Aquila G., and Carrieri B.

Subjects
Aging, medicine.medical_specialty, Sarcopenia, Socio-culturale, Acute care, Diabete, Diabetes mellitus, Internal medicine, 80 and over, medicine, Prevalence, Diabetes Mellitus, Humans, Diabetes, Mortality, Sarcopenic obesity, Aged, Aged, 80 and over, Hand Strength, Obesity, business.industry, Confounding, Diabetes Mellitu, medicine.disease, Original Article, Observational study, Geriatrics and Gerontology, business, Older people, Human
Abstract

Background Although the prevalence of sarcopenic obesity is increasing, nowadays a universally accepted definition still does not exist. Because, this clinical entity is defined as the combination of obesity and sarcopenia, the diagnosis appears to be strictly linked to criteria used for sarcopenia and the available prevalence data are not uniform. To investigate the prevalence of sarcopenic obesity in older persons according to EWGSOP2 and FNIH criteria. Second, to evaluate the prevalence of diabetes in patients with sarcopenia diagnosed by the two definitions. Methods Observational multicenter study performed in 2014 on older patients admitted to 12 Italian hospitals (GLISTEN Study). Data were collected through standardized questionnaires, which assessed: socio-demographic data, cognitive status, functional abilities, pharmacological therapy, comorbidities, and blood tests. Moreover, muscle mass and strength and physical performance were evaluated. Results Six hundred and ten were included in the analyses. Among sarcopenic patients, the prevalence of sarcopenic obesity was 30.8% with FNIH and 0% with EWGSOP2 criteria. According to EWGSOP2 criteria, 23.7% of sarcopenic and 30.8% of non-sarcopenic patients were affected by diabetes (p = 0.101); otherwise, using FNIH criteria, 36.3% of sarcopenic and 26.9% of non-sarcopenic patients were diabetic (p = 0.030). After adjustment for potential confounders, diabetic patients had a 73% higher probability of being sarcopenic according to FNIH criteria (OR 1.73; 95% CI 1.13–2.64). Conclusions The EWGSOP2 and FNIH sarcopenia criteria are differently related to the prevalence of obesity and diabetes. The EWGSOP2 criteria seem to be not suitable to identify people with sarcopenic obesity.

Published
2022

2. Association between hospitalization-related outcomes, dynapenia and body mass index: The Glisten Study

Author

Rossi, A, Fantin, F, Abete, P, Bellelli, G, Bo, M, Cherubini, A, Corica, F, Di Bari, M, Maggio, M, Manca, G, Rizzo, M, Bianchi, L, Landi, F, Volpato, S, Brombo, G, Maietti, E, Ortolani, B, Savino, E, Buttò, V, Fisichella, A, Carrarini, E, Zamboni, M, Di Meo, M, Orso, F, Sacco, F, Bonfanti, A, Cerri, A, Motta, M, Pittella, F, Fusco, S, Giarritta, V, Soraci, L, Agosta, L, Marchese, L, Basile, C, Fava, I, Coppola, C, Dalise, A, Salaris, P, Catte, O, Orru, M, Ortolani, E, Martone, A, Salini, S, Carrieri, B, Dell’Aquila, G, Rossi, Andrea P, Fantin, Francesco, Abete, Pasquale, Bellelli, Giuseppe, Bo, Mario, Cherubini, Antonio, Corica, Francesco, Di Bari, Mauro, Maggio, Marcello, Manca, Giovanna Maria, Rizzo, Maria Rosaria, Bianchi, Lara, Landi, Francesco, Volpato, Stefano, Brombo, Gloria, Maietti, Elisa, Ortolani, Beatrice, Savino, Elisabetta, Buttò, Valeria, Fisichella, Alberto, Carrarini, Elisa, Zamboni, Mauro, Di Meo, Maria Laura, Orso, Francesco, Sacco, Flavia, Bonfanti, Alessandra, Cerri, Anna Paola, MOTTA, MARCO, Pittella, Francesca, Fusco, Sergio, Giarritta, Valeria Prestipino, Soraci, Luca, Agosta, Luca, Marchese, Lorenzo, Basile, Claudia, Fava, Ilaria, Coppola, Carla, Dalise, Anna Maria, Salaris, Paolo, Catte, Olga, Orru, Maura, Ortolani, Elena, Martone, Anna Maria, Salini, Sara, Carrieri, Barbara, Dell’Aquila, Giuseppina, Rossi, A, Fantin, F, Abete, P, Bellelli, G, Bo, M, Cherubini, A, Corica, F, Di Bari, M, Maggio, M, Manca, G, Rizzo, M, Bianchi, L, Landi, F, Volpato, S, Brombo, G, Maietti, E, Ortolani, B, Savino, E, Buttò, V, Fisichella, A, Carrarini, E, Zamboni, M, Di Meo, M, Orso, F, Sacco, F, Bonfanti, A, Cerri, A, Motta, M, Pittella, F, Fusco, S, Giarritta, V, Soraci, L, Agosta, L, Marchese, L, Basile, C, Fava, I, Coppola, C, Dalise, A, Salaris, P, Catte, O, Orru, M, Ortolani, E, Martone, A, Salini, S, Carrieri, B, Dell’Aquila, G, Rossi, Andrea P, Fantin, Francesco, Abete, Pasquale, Bellelli, Giuseppe, Bo, Mario, Cherubini, Antonio, Corica, Francesco, Di Bari, Mauro, Maggio, Marcello, Manca, Giovanna Maria, Rizzo, Maria Rosaria, Bianchi, Lara, Landi, Francesco, Volpato, Stefano, Brombo, Gloria, Maietti, Elisa, Ortolani, Beatrice, Savino, Elisabetta, Buttò, Valeria, Fisichella, Alberto, Carrarini, Elisa, Zamboni, Mauro, Di Meo, Maria Laura, Orso, Francesco, Sacco, Flavia, Bonfanti, Alessandra, Cerri, Anna Paola, MOTTA, MARCO, Pittella, Francesca, Fusco, Sergio, Giarritta, Valeria Prestipino, Soraci, Luca, Agosta, Luca, Marchese, Lorenzo, Basile, Claudia, Fava, Ilaria, Coppola, Carla, Dalise, Anna Maria, Salaris, Paolo, Catte, Olga, Orru, Maura, Ortolani, Elena, Martone, Anna Maria, Salini, Sara, Carrieri, Barbara, and Dell’Aquila, Giuseppina

Abstract

Objective: To compare the prognostic value of dynapenia, as evaluated by handgrip, and body mass index (BMI) on length of stay (LOS), days of bed rest, and other hospitalization-related outcomes in a population of older adults admitted to 12 italian acute care divisions. Methods: Data on age, weight, BMI, comorbidities, ADL, physical activity level, muscle strength, were recorded at hospital admission. LOS, days of bed rest, intrahospital falls, and discharge destination were also recorded during the hospitalization. Subjects with BMI <18.5 kg/m2 were classified as underweight, subjects with BMI 18.5–24.9 as normal weight, subjects with BMI ≥25 as overweight-obese. Results: A total of 634 patients, mean age 80.8 ± 6.7 years and 49.4% women, were included in the analysis. Overall dynapenic subjects (D) showed a longer period of LOS and bed rest compared with non-dynapenic (ND). When the study population was divided according to BMI categories, underweight (UW), normal weight (NW), and overweight-obese (OW-OB), no significant differences were observed in hospital LOS and days of bed rest. When analysis of covariance was used to determine the difference of LOS across handgrip/BMI groups, D/OW-OB and D/UW subjects showed significantly longer LOS (11.32 and 10.96 days, both p 0.05) compared to ND/NW subjects (7.69 days), even when controlling for age, gender, baseline ADL, cause of hospitalization and comorbidity. After controlling for the same confounding factors, D/OW-OB, D/NW and D/UW subjects showed significantly longer bed rest (4.7, 4.56, and 4.05 days, respectively, all p 0.05, but D/OW-OB p 0.01) compared to ND/NW subjects (1.59 days). Conclusion: In our study population, LOS is longer in D/UW and D/OW-OB compared to ND/NW subjects and days of bed rest are mainly influenced by dynapenia, and not by BMI class.

Published
2019

3. Association between hospitalization-related outcomes, dynapenia and body mass index: The Glisten Study

Author

Rossi A P, Fantin F, Abete P, Bellelli G, Bo M, Cherubini A, Corica F, Di Bari, M Maggio, M Manca, G M Rizzo, M R Bianchi, L Landi, F Volpato, S Brombo, G Maietti, E Ortolani, B Savino, E Buttò, V Fisichella, A Carrarini, E Zamboni, M, Di Meo, M L Orso, F Sacco, F Bonfanti, A Cerri, A P Motta, M Pittella, F Fusco, S Giarritta, V P Soraci, L Agosta, L Marchese, L Basile, C Fava, I Coppola, C Dalise, A M Salaris, P Catte, O Orru, M Ortolani, E Martone, A M Salini, S Carrieri, B Dell’Aquila, G, Rossi, A. P., Fantin, F., Abete, P., Bellelli, G., Bo, M., Cherubini, A., Corica, F., Di Bari, M., Maggio, M., Manca, G. M., Rizzo, M. R., Bianchi, L., Landi, F., Volpato, S., Brombo, G., Maietti, E., Ortolani, B., Savino, E., Butto, V., Fisichella, A., Carrarini, E., Zamboni, M., Di Meo, M. L., Orso, F., Sacco, Filomena, Bonfanti, A., Cerri, A. P., Motta, M., Pittella, F., Fusco, S., Giarritta, V. P., Soraci, L., Agosta, L., Marchese, L., Basile, C., Fava, I., Coppola, C., Dalise, A. M., Salaris, P., Catte, O., Orru, M., Ortolani, E., Martone, A. M., Salini, S., Carrieri, B., Dell'Aquila, G., Rossi, A, Fantin, F, Abete, P, Bellelli, G, Bo, M, Cherubini, A, Corica, F, Di Bari, M, Maggio, M, Manca, G, Rizzo, M, Bianchi, L, Landi, F, Volpato, S, Brombo, G, Maietti, E, Ortolani, B, Savino, E, Buttò, V, Fisichella, A, Carrarini, E, Zamboni, M, Di Meo, M, Orso, F, Sacco, F, Bonfanti, A, Cerri, A, Motta, M, Pittella, F, Fusco, S, Giarritta, V, Soraci, L, Agosta, L, Marchese, L, Basile, C, Fava, I, Coppola, C, Dalise, A, Salaris, P, Catte, O, Orru, M, Ortolani, E, Martone, A, Salini, S, Carrieri, B, Dell’Aquila, G, Rossi, A P, Di, Bari, M, Maggio, M, Manca, G, M Rizzo, M, R Bianchi, L, Landi, F, Volpato, S, Brombo, G, Maietti, E, Ortolani, B, Savino, E, Buttò, V, Fisichella, A, Carrarini, E, Zamboni, M, Di, Meo, M, L Orso, F, Sacco, F, Bonfanti, A, Cerri, A, P Motta, M, Pittella, F, Fusco, S, Giarritta, V, P Soraci, L, Agosta, L, Marchese, L, Basile, C, Fava, I, Coppola, C, Dalise, A, M Salari, P, Catte, O, Orru, M, Ortolani, E, Martone, A, M Salini, S, Carrieri, B, Dell’Aquila, and G

Subjects
0301 basic medicine, Male, medicine.medical_specialty, medicine.medical_treatment, Population, Socio-culturale, Medicine (miscellaneous), 030209 endocrinology & metabolism, Bed rest, Body Mass Index, 03 medical and health sciences, 0302 clinical medicine, Acute care, Internal medicine, medicine, Humans, Obesity, education, Aged, 80 and over, education.field_of_study, 030109 nutrition & dietetics, Muscle Weakness, Nutrition and Dietetics, Hand Strength, business.industry, Confounding, Length of Stay, medicine.disease, Comorbidity, Hospitalization, Italy, Socioeconomic Factors, Population study, Female, Underweight, medicine.symptom, business, Body mass index
Abstract

Objective: To compare the prognostic value of dynapenia, as evaluated by handgrip, and body mass index (BMI) on length of stay (LOS), days of bed rest, and other hospitalization-related outcomes in a population of older adults admitted to 12 italian acute care divisions. Methods: Data on age, weight, BMI, comorbidities, ADL, physical activity level, muscle strength, were recorded at hospital admission. LOS, days of bed rest, intrahospital falls, and discharge destination were also recorded during the hospitalization. Subjects with BMI

Published
2019

4. Polypharmacy and sarcopenia in hospitalized older patients: results of the GLISTEN study

Author

Agosta, Luca, Mario, Bo, Bianchi, Lara, Abete, Pasquale, Belelli, Giuseppe, Cherubini, Antonio, Corica, Francesco, Di Bari, Mauro, Maggio, Marcello, Manca, Giovanna Maria, Rizzo, Maria Rosaria, Rossi, Andrea, Landi, Francesco, Volpato, Stefano, Brombo, Gloria, Ortolani, Beatrice, Savino, Elisabetta, Maietti, Elisa, Fisichella, Alberto, Buttò, Valeria, Zamboni, Mauro, Caliari, Cesare, Ferrari, Elena, Orso, Francesco, Sacco, Flavia, Di meo, Laura, Cerri, Anna Paola, Motta, Marco, Pittella, Francesca, Bonfanti, Alessandra, Fusco, Sergio, PRESTIPINO GIARRITTA, Valeria, Soraci, Luca, Pili, Fausto Giordano, Basile, Claudia, Coppola, Carla, Dalise, Anna Maria, Fava, Ilaria, Catte, Olga, Orrù, Maura, Salaris, Paolo, Martone, Anna Maria, Ortolani, Elena, Salini, Sara, Dell’Aquila, Giuseppina, Carrier, Barbara, Agosta, L., Bo, M., Bianchi, L., Abete, P., Belelli, G., Cherubini, A., Corica, F., Di Bari, M., Maggio, M., Manca, G. M., Rizzo, M. R., Rossi, A., Landi, F., Volpato, S., Brombo, G., Ortolani, B., Savino, E., Maietti, E., Fisichella, A., Butto, V., Zamboni, M., Caliari, C., Ferrari, E., Orso, F., Sacco, F., Dimeo, L., Cerri, A. P., Motta, M., Pittella, F., Bonfanti, A., Fusco, S., Prestipinogiarritta, V., Soraci, L., Pili, F. G., Basile, C., Coppola, C., Dalise, A. M., Fava, I., Catte, O., Orru, M., Salaris, P., Martone, A. M., Ortolani, E., Salini, S., Dell'Aquila, G., and Carrier, B.

Subjects
Gerontology, Male, Aging, medicine.medical_specialty, In-patients, Sarcopenia, Polypharmacy, Skeletal muscle, Aged, Aged, 80 and over, Cross-Sectional Studies, Female, Humans, Independent Living, Italy, Prevalence, Risk Factors, Geriatric Assessment, Socio-culturale, Geriatrics and Gerontology, 03 medical and health sciences, 0302 clinical medicine, Older patients, Acute care, medicine, 80 and over, 030212 general & internal medicine, Cross-Sectional Studie, High prevalence, business.industry, Risk Factor, musculoskeletal system, medicine.disease, body regions, In-patient, Older people, business, human activities, 030217 neurology & neurosurgery, Human
Abstract

Background: Recently the Berlin Aging Study II (BASE-II) showed that polypharmacy is associated with clinically relevant sarcopenia among community-dwelling older persons. Here we report findings from the GLISTEN study about the association of polypharmacy with sarcopenia among older medical in-patients. Methods: The GLISTEN study investigated prevalence and clinical correlates of sarcopenia in older patients admitted to geriatric and internal medicine acute care wards of 12 Italian hospitals. Results: In this sample of older medical in-patients with high prevalence of sarcopenia (34.7%) and polypharmacy (70.2%) we did not observe a significant association of polypharmacy with sarcopenia. Conclusions: Present findings demonstrate that the association of polypharmacy with sarcopenia, observed in the BASE-II study, is not evident in the GLISTEN sample, being our patients significantly older, more multi-morbid, with high prevalence of sarcopenia and polypharmacy, suggesting that this association might vary according to the heterogeneous health, functional, and nutritional characteristics of older people.

Published
2019

5. Total body and arm bioimpedance in patients with Alzheimer's disease.

Author

Mereu E, Succa V, Buffa R, Sanna C, Mereu RM, Catte O, and Marini E

Subjects
Adiposity, Aged, Aged, 80 and over, Alzheimer Disease diagnosis, Body Mass Index, Case-Control Studies, Electric Impedance, Female, Humans, Italy, Male, Predictive Value of Tests, Alzheimer Disease physiopathology, Body Composition, Upper Extremity physiopathology
Abstract

Purpose of the Research: To analyse body composition of patients with Alzheimer's disease (AD) using total body and localized specific bioelectrical impedance vector analysis (specific BIVA)., Method: 127 patients (50 men, 78.2±6.3years; 77 women, 81.4±6.8years) with mild to moderate stages of AD were selected from the Geriatric Division, SS. Trinità Hospital of Cagliari (Italy). A sample of 135 healthy age-matched individuals (74 men, 77.4±5.3years; 61 women, 80.4±5.5years) was chosen as control group. Anthropometric measurements were taken and body mass index (BMI) was calculated. Bioelectrical measurements were taken on the right side of the body for both the whole-body and the arm, using a BIA 101 analyser (Akern). Body composition was assessed by means of specific bioelectrical impedance vector analysis (specific BIVA). The comparison between patients and the control group was performed by two-factor analysis of variance and Hotelling's T 2 test., Results: In comparison with the control group, patients with AD showed similar anthropometric characteristics, including BMI, but lower lean tissue mass and higher percent fat mass, as indicated by the lower phase angles and longer specific vectors. The same body composition peculiarities were detected considering only the right arm., Conclusion: Patients with AD show characteristics - lower lean mass/higher percent fat mass - that can be detected by both total body and localized bioimpedance approaches. This suggests the possibility of a new, quicker and simpler procedure for body composition assessment., (Copyright © 2017 Elsevier Inc. All rights reserved.)

Published
2018
Full Text
View/download PDF

6. Cognitive Impairment and Age-Related Vision Disorders: Their Possible Relationship and the Evaluation of the Use of Aspirin and Statins in a 65 Years-and-Over Sardinian Population.

Author

Mandas A, Mereu RM, Catte O, Saba A, Serchisu L, Costaggiu D, Peiretti E, Caminiti G, Vinci M, Casu M, Piludu S, Fossarello M, Manconi PE, and Dessí S

Abstract

Neurological disorders (Alzheimer's disease, vascular and mixed dementia) and visual loss (cataract, age-related macular degeneration, glaucoma, and diabetic retinopathy) are among the most common conditions that afflict people of at least 65 years of age. An increasing body of evidence is emerging, which demonstrates that memory and vision impairment are closely, significantly, and positively linked and that statins and aspirin may lessen the risk of developing age-related visual and neurological problems. However, clinical studies have produced contradictory results. Thus, the intent of the present study was to reliably establish whether a relationship exist between various types of dementia and age-related vision disorders, and to establish whether statins and aspirin may or may not have beneficial effects on these two types of disorders. We found that participants with dementia and/or vision problems were more likely to be depressed and displayed worse functional ability in basic and instrumental activities of daily living than controls. Mini mental state examination scores were significantly lower in patients with vision disorders compared to subjects without vision disorders. A closer association with macular degeneration was found in subjects with Alzheimer's disease than in subjects without dementia or with vascular dementia, mixed dementia, or other types of age-related vision disorders. When we considered the associations between different types of dementia and vision disorders and the use of statins and aspirin, we found a significant positive association between Alzheimer's disease and statins on their own or in combination with aspirin, indicating that these two drugs do not appear to reduce the risk of Alzheimer's disease or improve its clinical evolution and may, on the contrary, favor its development. No significant association in statin use alone, aspirin use alone, or the combination of these was found in subjects without vision disorders but with dementia, and, similarly, none in subjects with vision disorders but without dementia. Overall, these results confirm the general impression so far; namely, that macular degeneration may contribute to cognitive disorders (Alzheimer's disease in particular). In addition, they also suggest that, while statin and aspirin use may undoubtedly have some protective effects, they do not appear to be magic pills against the development of cognitive impairment or vision disorders in the elderly.

Published
2014
Full Text
View/download PDF

7. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.

Author

Cossu G, Melis M, Melis G, Maccioni E, Putzu V, Catte O, and Putzu PF

Subjects
Aged, Alzheimer Disease diagnosis, Botulinum Toxins, Type A therapeutic use, Cholinesterase Inhibitors therapeutic use, Cognition Disorders diagnosis, Cognition Disorders drug therapy, Dystonia drug therapy, Dystonia physiopathology, Female, Galantamine therapeutic use, Humans, Neuromuscular Agents therapeutic use, Neuropsychological Tests, Severity of Illness Index, Syndrome, Alzheimer Disease drug therapy, Cholinesterase Inhibitors adverse effects, Dystonia chemically induced, Galantamine adverse effects
Abstract

We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type-A injection., ((c) 2004 Movement Disorder Society.)

Published
2004
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results